TERN position history
The shares of Terns Pharmaceuticals (TERN) that SOROS FUND MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 321,905 shares, $17M, 0.19% of portfolio, New
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|